Test–retest reliability of 11C-ORM-13070 in PET imaging of α2C-adrenoceptors in vivo in the human brain

2014 ◽  
Vol 42 (1) ◽  
pp. 120-127 ◽  
Author(s):  
Jussi Lehto ◽  
Jere R. Virta ◽  
Vesa Oikonen ◽  
Anne Roivainen ◽  
Pauliina Luoto ◽  
...  
2019 ◽  
Vol 22 (5) ◽  
pp. 329-338 ◽  
Author(s):  
Louisa J Steinberg ◽  
Harry Rubin-Falcone ◽  
Hanga C Galfalvy ◽  
Joshua Kaufman ◽  
Jeffrey M Miller ◽  
...  

2015 ◽  
Vol 35 (7) ◽  
pp. 1199-1205 ◽  
Author(s):  
Kati Alakurtti ◽  
Jarkko J Johansson ◽  
Juho Joutsa ◽  
Matti Laine ◽  
Lars Bäckman ◽  
...  

We measured the long-term test–retest reliability of [11C]raclopride binding in striatal subregions, the thalamus and the cortex using the bolus-plus-infusion method and a high-resolution positron emission scanner. Seven healthy male volunteers underwent two positron emission tomography (PET) [11C]raclopride assessments, with a 5-week retest interval. D2/3 receptor availability was quantified as binding potential using the simplified reference tissue model. Absolute variability (VAR) and intraclass correlation coefficient (ICC) values indicated very good reproducibility for the striatum and were 4.5%/0.82, 3.9%/0.83, and 3.9%/0.82, for the caudate nucleus, putamen, and ventral striatum, respectively. Thalamic reliability was also very good, with VAR of 3.7% and ICC of 0.92. Test-retest data for cortical areas showed good to moderate reproducibility (6.1% to 13.1%). Our results are in line with previous test–retest studies of [11C]raclopride binding in the striatum. A novel finding is the relatively low variability of [11C]raclopride binding, providing suggestive evidence that extrastriatal D2/3 binding can be studied in vivo with [11C]raclopride PET to be verified in future studies.


2015 ◽  
Vol 35 (8) ◽  
pp. 1313-1322 ◽  
Author(s):  
Marc D Normandin ◽  
Ming-Qiang Zheng ◽  
Kuo-Shyan Lin ◽  
N Scott Mason ◽  
Shu-Fei Lin ◽  
...  

The Radiotracer [11C]OMAR was developed for positron emission tomography (PET) imaging of cannabinoid type-1 receptors (CB1R). The objectives of the present study were to evaluate kinetic analysis methods, determine test–retest reliability, and assess gender differences in receptor availability. Dynamic PET data were acquired in 10 human subjects, and analyzed with one-tissue (1T) and two-tissue (2T) compartment models and by the Logan and multilinear analysis (MA1) methods to estimate regional volume of distribution ( VT). The 2T model inclusive of a vascular component (2TV) and MA1 were the preferred techniques. Test–retest reliability of VT was good (mean absolute deviation ~ 9%; intraclass correlation coefficient ~ 0.7). Tracer parent fraction in plasma was lower in women ( P < 0.0001). Cerebral uptake normalized by body weight and injected dose was higher in men by 17% ( P < 0.0001), but VT was significantly greater in women by 23% ( P < 0.0001). These findings show that [11C]OMAR binding can be reliably quantified by the 2T model or MA1 method and demonstrate the utility of this tracer for in vivo imaging of CB1R. In addition, results from the present study indicate that gender difference in receptor binding should be taken into consideration when [11C]OMAR is used to quantify CB1R availability in neuropsychiatric disorders.


2020 ◽  
Vol 4 (3) ◽  
pp. 925-945
Author(s):  
Leonardo Tozzi ◽  
Scott L. Fleming ◽  
Zachary D. Taylor ◽  
Cooper D. Raterink ◽  
Leanne M. Williams

Countless studies have advanced our understanding of the human brain and its organization by using functional magnetic resonance imaging (fMRI) to derive network representations of human brain function. However, we do not know to what extent these “functional connectomes” are reliable over time. In a large public sample of healthy participants ( N = 833) scanned on two consecutive days, we assessed the test-retest reliability of fMRI functional connectivity and the consequences on reliability of three common sources of variation in analysis workflows: atlas choice, global signal regression, and thresholding. By adopting the intraclass correlation coefficient as a metric, we demonstrate that only a small portion of the functional connectome is characterized by good (6–8%) to excellent (0.08–0.14%) reliability. Connectivity between prefrontal, parietal, and temporal areas is especially reliable, but also average connectivity within known networks has good reliability. In general, while unreliable edges are weak, reliable edges are not necessarily strong. Methodologically, reliability of edges varies between atlases, global signal regression decreases reliability for networks and most edges (but increases it for some), and thresholding based on connection strength reduces reliability. Focusing on the reliable portion of the connectome could help quantify brain trait-like features and investigate individual differences using functional neuroimaging.


2013 ◽  
Vol 3 (2) ◽  
pp. 160-176 ◽  
Author(s):  
Julia P. Owen ◽  
Etay Ziv ◽  
Polina Bukshpun ◽  
Nicholas Pojman ◽  
Mari Wakahiro ◽  
...  

2019 ◽  
Vol 51 (4) ◽  
pp. 1181-1191 ◽  
Author(s):  
Arwa Baeshen ◽  
Patrik O. Wyss ◽  
Anke Henning ◽  
Ruth L. O'Gorman ◽  
Marco Piccirelli ◽  
...  

2011 ◽  
Vol 66 (2) ◽  
pp. 324-332 ◽  
Author(s):  
Charles Gasparovic ◽  
Edward J. Bedrick ◽  
Andrew R. Mayer ◽  
Ronald A. Yeo ◽  
HongJi Chen ◽  
...  

2019 ◽  
Vol 40 (9) ◽  
pp. 1859-1868 ◽  
Author(s):  
Nina Karalija ◽  
Lars Jonassson ◽  
Jarkko Johansson ◽  
Goran Papenberg ◽  
Alireza Salami ◽  
...  

In vivo dopamine D2-receptor availability is frequently assessed with 11C-raclopride and positron emission tomography. Due to low signal-to-noise ratios for 11C-raclopride in areas with low D2 receptor densities, the ligand has been considered unreliable for measurements outside the dopamine-dense striatum. Intriguingly, recent studies show that extrastriatal 11C-raclopride binding potential (BPND) values are (i) reliably higher than in the cerebellum (where D2-receptor levels are negligible), (ii) correlate with behavior in the expected direction, and (iii) showed good test–retest reliability in a sample of younger adults. The present work demonstrates high seven-month test–retest reliability of striatal and extrastriatal 11C-raclopride BPND values in healthy, older adults (n = 27, age: 64–78 years). Mean 11C-raclopride BPND values were stable between test sessions in subcortical nuclei, and in frontal and temporal cortices (p > 0.05). Across all structures analyzed, intraclass correlation coefficients were high (0.85–0.96), absolute variability was low (mean: 4–8%), and coefficients of variance ranged between 9 and 25%. Furthermore, regional 11C-raclopride BPND values correlated with previously determined 18F-fallypride BPND values (ρ = 0.97 and 0.92 in correlations with and without striatal values, respectively, p < 0.01) and postmortem determined D2-receptor densities (including striatum: ρ = 0.92; p < 0.001; excluding striatum: ρ = 0.75; p = 0.067). These observations suggest that extrastriatal 11C-raclopride measurements represent a true D2 signal.


Sign in / Sign up

Export Citation Format

Share Document